Compare · 2 funds side by side · dividends reinvested

XBI and MDEV

XBISPDR×MDEVFirst Trust×

Versus in desk

02 / 04

IWD−0.4%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$11,423XBI · best of the two

Story of the two · IncomeMost incomeXBI · 0.36% · $36 a year on $10k

Story of the two · RiskSmallest drop

XBI and MDEV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street SPDR S&P Biotech ETFSectors · Health care0.35%0.36%+24.1%+33.2%+28.6%+2.7%−14.9%30.2%$10.5B1.1

First Trust Indxx Medical Devices ETFSectors · Health care0.70%0.10%+7.2%+7.3%+9.7%−3.1%−18.2%17.5%$3M1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 12, 2026 · returns include dividends · since: XBI 2006 · MDEV 2021

Head to Head

Swap sides Versus in desk

Head to Head

5Y

First Trust Indxx Medical Devices ETF · $3M$8,559

MDEV

XBI

State Street SPDR S&P Biotech ETF · $10.5B$11,423

$10,000 five years ago, dividends reinvested · they hold 0.0% in common

MDEVMeasureXBI

+7.2%

More Ways to See the Pairs

MDEV vs XBI: Top 5 Holdings

Today

MDEV

11.6%in top 5

XBI

in top 59.7%

MDEVStockXBI

not top 5MRNA2.7%

2.3%GEHCnot top 5

2.3%TFXnot top 5

2.3%EWnot top 5

2.3%PHIA.ASnot top 5

Cost, Income and Risk

Fees: XBI, MDEV

Today

0.35%lowest, XBI

FundExpense ratioFee$10k

XBI0.35%$35

MDEV0.70%$70

End-of-day Nov 12, 2026 · fee on $10,000 a year

Yields: XBI, MDEV

1Y

0.36%highest, XBI

FundTrailing yieldYield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+34.2%

VIGVanguard

+16.0%

+34.2%Year to date+16.0%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 12, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.8%

JEPIJ.P. Morgan

+8.3%

SPYM vs SPY

YTD

SPDRSPYM

+12.0%

SPYSPDR

+11.9%

Year to dateJan 1 → Nov 12

+24.1%

+7.3%1 yearTotal return+33.2%

+9.7%3 years · per year$10,000 became $13,188 · $21,275+28.6%

−3.1%5 years · per year$10,000 became $8,559 · $11,423+2.7%

0.70%Expense ratio$70 · $35 a year on $10k · lower is better0.35%

0.10%Trailing 12-mo yield$10 · $36 a year on $10k0.36%

−18.2%Worst dropSmaller is better−14.9%

17.5%VolatilityLower is calmer30.2%

MDEVXBI Winner of the row, in its colourEach row: the bigger of the two fills its side

1–7XBI wins

End-of-day Nov 12, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

2.3%ZBHnot top 5

not top 5SYRE1.8%

not top 5EXEL1.8%

not top 5TGTX1.7%

not top 5BIIB1.7%

Held in common0.0%

End-of-day Nov 12, 2026 · share of each fund

MDEV vs XBI Returns, Every Period

5Y

First TrustMDEV

−3.1%

5 years, per year

XBISPDR

+2.7%

5 years, per year

MDEVXBIFaded: behind in that period

0–4XBI wins

End-of-day Nov 12, 2026 · dividends in · faded = behind in that period

MDEV vs XBI

YTD

First TrustMDEV

+7.2%

XBISPDR

+24.1%

+7.2%Year to date+24.1%

−18.2%Worst drop · 1Y−14.9%

17.5%Volatility · 1Y30.2%

0.1%Yield0.4%

$3.4MAssets$10.5B

3–1XBI wins

End-of-day Nov 12, 2026 · smaller drop and lower volatility win

$10k

XBI0.36%$36

MDEV0.10%$10

End-of-day Nov 12, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$1most kept, XBI

XBI$36 − $35 = $1

MDEV$10 − $70 = −$60

KeptFee

End-of-day Nov 12, 2026 · yield in dollars minus the fee

Overlap: XBI, MDEV

Today

0.0%most shared, XBI and MDEV

XBIMDEV

XBI—0.0%

MDEV0.0%—

End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+33.2%XBI, at 30.2% volatility

MDEVWorst drop−18.2%17.5% vol

XBIWorst drop−14.9%30.2% vol

End-of-day Nov 12, 2026 · up and left is better

Paid More vs Made More

YTD

XBIMDEV

+24.1%Year to date+7.2%

0.4%Yield0.1%

+33.2%Past year+7.3%

0.35%Fee0.70%

4–0XBI wins

End-of-day Nov 12, 2026

+7.8%Year to date+8.3%

12.2%Yield7.9%

$41.8BAssets$46.8B

1–1level

End-of-day Nov 12, 2026

+12.0%Year to date+11.9%

1.0%Yield1.0%

$183BAssets$793B

1–0SPYM wins

End-of-day Nov 12, 2026

Loading…

XBI and MDEV

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two